cbdMD, Inc.(YCBD)Earnings, Financials & Key RatioscbdMD, Inc. (YCBD) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q2
the company's inability to achieve profitability, combined with a deeply negative free cash flow margin of -12.9% in 2026Q2, presents a high risk of continued equity dilution and potential insolvency.
cbdMD, Inc. (YCBD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Recent stock market news and headlines for cbdMD, Inc. (YCBD)
Years of peer-reviewed safety research position cbdMD's broad spectrum CBD for a new era of evidence-based, clinically supported wellness. CHARLOTTE, N.C.
A quadruple-filtered, zero-proof spirit with a resealable, child-resistant cap; ready to enjoy on its own or built into a mocktail CHARLOTTE, N.C., July 1, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD) today announced that its hemp-derived THC ("THC") beverage brand, Herbal Oasis ("Oasis"), has launched Oasis Mixer, a translucent, zero-proof THC spirit that blends into a wide range of beverages without the cloudy, murky appearance common to other THC mixers.
As federal reclassification efforts advance and major U.S. exchanges open to compliant operators, cbdMD points to its position as an established, NYSE American–listed company in a maturing cannabinoid category CHARLOTTE, N.C., June 25, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's most recognized and trusted hemp-derived wellness companies, today welcomed the Administration's call urging Congress to ensure the fair treatment of hemp-derived products under federal law and requesting immediate action to revise federal hemp regulation to ensure fair treatment of hemp products under federal law.
Veteran consumer-wellness growth operator to lead multi-brand expansion across DTC, Amazon, retail, and new categories CHARLOTTE, N.C., June 16, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted cannabinoid wellness companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its THC beverage brand Oasis, today announced the appointment of Wade Brown as Chief Marketing Officer.
Key metrics vs top competitors for cbdMD, Inc. (YCBD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.74 | $7.75M | -0.68 | -1.5% | -10.63% | -44.42% | — | |
| $4.31 | $502.21M | -0.13 | 4.84% | -252.55% | -136.55% | — | |
| $0.95 | $365.74M | -1.53 | 5.8% | -91.63% | -38.64% | — | |
| $2.67 | $165.39M | -1.77 | -6.37% | -24.14% | -13.4% | — | |
| $4.36 | $1.5M | -0.08 | -40.66% | -44.9% | -25.03% | — | |
| $9.71 | $90.09M | -3.01 | -3.76% | -31.46% | -7.65% | — |
cbdMD, Inc. (YCBD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
cbdMD, Inc. (YCBD) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 20, 2026·SEC
Apr 15, 2026·SEC
Apr 1, 2026·SEC
Get notified when YCBD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
cbdMD, Inc. (YCBD) stock FAQ — growth, dividends, profitability & financials explained
cbdMD, Inc. (YCBD) reported $20.0M in revenue for fiscal year 2025. This represents a 884% increase from $2.0M in 2016.
cbdMD, Inc. (YCBD) saw revenue decline by 1.5% over the past year.
cbdMD, Inc. (YCBD) reported a net loss of $2.7M for fiscal year 2025.
cbdMD, Inc. (YCBD) has a return on equity (ROE) of -44.4%. Negative ROE indicates the company is unprofitable.
cbdMD, Inc. (YCBD) had negative free cash flow of $166.5M in fiscal year 2025, likely due to heavy capital investments.
